Off-label use of oxaliplatin in patients with metastatic breast cancer

Anticancer Research

Volumn 31, Issue 5, 2011, Pages 1765-1767

  Delpeuch, Amina ^a   Leveque, Dominique ^a   Lynn, Rob ^a   Bergerat, Jean Pierre ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Metastatic breast cancer; Off label use; Oxaliplatin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; BLOOD TOXICITY; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; NEUROPATHY; OFF LABEL DRUG USE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN METASTASIS; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OFF-LABEL USE; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79958121240     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Levêque D: Off-label use of anticancer drugs. Lancet Oncol 9: 1102-1107, 2008.
2. Levêque D, Michallat AC, Schaller C and Rank M: Off-label drug use in adult patients treated by anticancer chemotherapy. Bull Cancer 92: 498-500, 2005. (Pubitemid 40852766)
3. Levêque D, Monteiro MC, Ranc M and Beretz L: Off-label anticancer drug use in adult patients: survey in a french teaching hospital. Pharm World Sci 26: A11 (abstract), 2004.
4. Garufi C, Nistico C, Brienza S, Vaccaro A, D'Ottavio A, Zappalà AR, Aschelter AM and Terzoli E: Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II study. Ann Oncol 12: 179-182, 2001. (Pubitemid 32223864)
5. Zelek L, Cottu P, Tubiana-Hulin M, Vannetzel JM, Chollet P, Misset JL, Chouaki N, Marty M, Gamelin E, Culine S, Dieras V, Mackenzie S and Spielmann M: Phase II study of oxaliplatin and fluorouracil in taxane and anthracycline-pretreated breast cancer patients. J Clin Oncol 20: 2551-2558, 2002. (Pubitemid 34525743)
6. Pectasides D, Pectasides M, Farmakis D, Bountouroglou N, Nikolaou M, Koumpou M, Mylonakis N and Kosmas C: Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study. Ann Oncol 14: 537-542, 2003. (Pubitemid 41295079)
7. Thuss-Patience PC, von Minckwitz G, Kretzschmar A, Loibl S, Schaller G, Dörken B, Reichardt P: Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study. Anti-cancer Drugs 14: 549-553, 2003. (Pubitemid 37083160)
8. Kakolyris S, Kalbakis K, Potamianou A, Malamos N, Vamvakas L, Christophillakis C, Tselepatiotis E, Giassas S, Mavroudis D, Amarantidis K and Georgoulias V: Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study. Oncology 70: 273-279, 2006. (Pubitemid 44670167)
9. Airoldi M, Cattel L, Passera R, Pedani F, Delprino L and Micari C: Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes. Am J Clin Oncol 29: 490-494, 2006. (Pubitemid 44536032)
10. Petit T, Benider A, Yovine A, Bougnoux P, Spaeth D, Maindrault-Goebel F, Serin D, Tigaud JD, Eymard JC, Simon H, Bertaux B, Brienza S and Cvitkovic E: Phase II study of an oxaliplatin/ vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer. Anti-cancer Drugs 17: 337-343, 2006.
11. Delozier T, Guastalla JP, Yovine A, Levy C, Chollet P, Mousseau M, Delva R, Coeffic D, Vannetzel JM, Zazzi ES, Brienza S and Cvitkovic E: Phase II study of an oxaliplatin/vinorelbine/5- fluorouracil combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer. Anti-cancer Drugs 17: 1067-1073, 2006. (Pubitemid 44454784)
12. Caruba T, Cottu PH, Madelaine-Chambrin I, Espié M, Misset JL and Gross-Goupil M: Gemcitabine-oxaliplatin combination in heavily pretreated metastatic breast cancer: a pilot study on 43 patients. Breast J 13: 165-171, 2007. (Pubitemid 46280601)
13. Polyzos A, Gogas H, Markopoulos C, Tsavaris N, Papadopoulos O, Polyzos K and Giannopoulos A: Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes. Anticancer Res 29: 2851-2856, 2009.